Stocks and Investing Stocks and Investing
Fri, January 6, 2023
Thu, January 5, 2023

David Amsellem Initiated (AXSM) at Hold and Held Target at $75 on, Jan 5th, 2023


Published on 2024-10-28 00:46:16 - WOPRAI, David Amsellem
  Print publication without navigation


David Amsellem of Piper Sandler, Initiated "Axsome Therapeutics, Inc." (AXSM) at Hold and Held Target at $75 on, Jan 5th, 2023.

David has made no other calls on AXSM in the last 4 months.



There are 7 other peers that have a rating on AXSM. Out of the 7 peers that are also analyzing AXSM, 1 agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Vikram Purohit of "Morgan Stanley" Maintained at Hold with Increased Target to $86 on, Tuesday, November 29th, 2022


These are the ratings of the 6 analyists that currently disagree with David


  • Robert Hazlett of "BTIG" Maintained at Strong Buy with Increased Target to $98 on, Friday, December 23rd, 2022
  • Marc Goodman of "SVB Leerink" Maintained at Buy with Increased Target to $85 on, Tuesday, November 29th, 2022
  • Yatin Suneja of "Guggenheim" Maintained at Strong Buy with Increased Target to $80 on, Friday, November 11th, 2022
  • Graig Suvannavejh of "Mizuho" Maintained at Strong Buy with Increased Target to $80 on, Wednesday, November 9th, 2022
  • Esther Hong of "Loop Capital" Initiated at Strong Buy and Held Target at $95 on, Tuesday, November 1st, 2022
  • Chris Howerton of "Jefferies" Maintained at Strong Buy with Decreased Target to $90 on, Friday, September 30th, 2022
Contributing Sources